Literature DB >> 31556774

Posterior reversible encephalopathy syndrome in pediatric patients: pathophysiology, diagnosis, and management.

Michael G Z Ghali1,2, Justin Davanzo2, Madeline Leo2, Elias Rizk2.   

Abstract

Posterior reversible encephalopathy syndrome (PRES) is well-described in adults, but has been reported with relative rarity in children, usually occurring in the context of chemotherapy for acute leukemia. Pathogenesis involves perturbed cerebral autoregulation leading to vasogenic edema predominantly affecting the parieto-occipital white matter, though involvement of the frontal and temporal lobes, as well as posterior fossa, is also described. We review the literature on the pathophysiology, diagnosis, and management of PRES in pediatric patients.

Entities:  

Keywords:  ALL; AML; PRES; chemotherapy; hypertension; leukemia; pathogenesis; reversible posterior leukoencephalopathy syndrome

Year:  2019        PMID: 31556774     DOI: 10.1080/10428194.2019.1594210

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  7 in total

1.  Posterior reversible encephalopathy syndrome: characteristics, diagnostic accuracy, prognostic factors and long-term outcome in a paediatric population.

Authors:  Catarina Marques Duarte; Ana Sofia Vilardouro; Duarte Rebelo; Sofia Quintas; Francisco Abecasis
Journal:  Acta Neurol Belg       Date:  2021-10-24       Impact factor: 2.396

2.  Clinical features, predictors and outcome of posterior reversible encephalopathy syndrome (PRES) in children with hematolymphoid malignancies.

Authors:  Subramaniam Ramanathan; Vignesh Subramani; Seema Kembhavi; Maya Prasad; Nirmalya Roy Moulik; Chetan Dhamne; Gaurav Narula; Shripad Banavali
Journal:  Childs Nerv Syst       Date:  2022-05-25       Impact factor: 1.532

3.  A Case of Pediatric Posterior Reversible Encephalopathy Syndrome (PRES) Secondary to Post-streptococcal Glomerulonephritis: A Literature Review and Assessment of Treatment Modalities.

Authors:  Abdurrahman F Kharbat; Pedro Calles; Allison Ogle; Tetyana L Vasylyeva; Kerrie Pinkney
Journal:  Cureus       Date:  2022-05-18

4.  Different Clinicoradiological Characteristics of Posterior Reversible Encephalopathy Syndrome in Pediatric Oncology and Post-Bone Marrow Transplantation Cases: A Retrospective Study.

Authors:  Hwazen Shash; Saad Aldaama; Hala Omer; Sameera Alafghani
Journal:  Front Neurol       Date:  2022-05-06       Impact factor: 4.086

Review 5.  A Review of Acute and Long-Term Neurological Complications Following Haematopoietic Stem Cell Transplant for Paediatric Acute Lymphoblastic Leukaemia.

Authors:  Melissa Gabriel; Bianca A W Hoeben; Hilde Hylland Uhlving; Olga Zajac-Spychala; Anita Lawitschka; Dorine Bresters; Marianne Ifversen
Journal:  Front Pediatr       Date:  2021-12-23       Impact factor: 3.418

6.  Management and Clinical Outcome of Posterior Reversible Encephalopathy Syndrome in Pediatric Oncologic/Hematologic Diseases: A PRES Subgroup Analysis With a Large Sample Size.

Authors:  Marady Hun; Min Xie; Zhou She; Amin S Abdirahman; Cuifang Li; Feifeng Wu; Senlin Luo; Phanna Han; Rithea Phorn; Pan Wu; Haiyan Luo; Keke Chen; Jidong Tian; Wuqing Wan; Chuan Wen
Journal:  Front Pediatr       Date:  2021-07-01       Impact factor: 3.418

7.  Long-Term Follow-Up of Patients with a Diagnosis of Posterior Reversible Encephalopathy Syndrome.

Authors:  Mehmet Canpolat; Gül Demet Kaya Özçora; Hakan Poyrazoğlu; Huseyin Per; Abdulhakim Çoşkun; Hakan Gümüş; Duran Arslan; Ekrem Ünal; Musa Karakükçü; Türkan Patıroğlu; Sefer Kumandaş
Journal:  Turk Arch Pediatr       Date:  2021-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.